Applications Published 25 July 2001

Published: 30-Apr-2002

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Compsns and methods for enhancing receptor-mediated cellular internalisation
    The Penn State Research Foundation 1117378*

  • Glucoside paucilamellar vesicles
    Igen 1117380*

  • Calcium phosphate delivery vehicle and adjuvant
    Etex Corp 1117381*

  • Spray coated microparticles for use in needleless syringes
    Powderject Research 1117382*

  • Dosage form comprising therapeutic formulation
    Alza Corp 1117383*

  • Controlled release nanoparticulate compsns
    Elan Pharma International 1117384*

  • Aqueous enteric coating compsn with low gastric permeability
    Eastman Chemical 1117385*

  • Enteric and colinic delivery using HPMC capsules
    Warner-Lambert 1117386*

  • Coated medicament forms with controlled active substance release
    Roehm 1117387*

  • Antixidant gel for gingivitis conditions
    Thione International 1117388*

  • Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs
    TheraTech 1117389*

  • Mucosal originated drug delivery systems and animal applications
    3M Innovative Properties Company 1117390*

  • Method for treating multiple sclerosis
    Shankar, L Sai Latha; Tatton, William G; Tatton, Nadine A 1117391*

  • Use of acylcarnitines as antitumour agents
    Universta' Degli Studi Di Catania 1117393*

  • Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders
    Sigma-Tau Healthscience 1117394*

  • Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
    Duquesne University of the Holy Ghost 1117395*

  • A method to increase the excretion of non-sterol endogenous hydrophobic substances by increasing excretion of fat via the faeces
    Verkade, Hendrik Jan 1117396*

  • Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
    Sugen 1117397*

  • A method for treating inflammatory diseases by administering a thrombin inhibitor
    Merck 1117398*

  • Antibiotic compsns for treatment of the eye, ear and nose
    Alcon Labs 1117400*

  • Antibiotic compsns for treatment of the eye, ear and nose
    Alcon Labs 1117402*

  • MGLUR5 antagonists for the treatment of pain and anxiety
    Novartis 1117403*

  • Compsn for the treatment of light-injured retinal degeneration disease
    Sucampo 1117404*

  • Compsn and method for treating allergic diseases
    Schering 1117405*

  • Antibiotic compsns for treatment of the eye, ear and nose
    Alcon Labs 1117406*

  • Oral dosage compsn comprising (2S,3S,5R)-2-(3,5-dimethyl-2-morpholinol and an effective stabilising amount of alginic acid
    Glaxo Group 1117407*

  • Use of dilitiazem for treating retinal pathologies
    Institut National de la Sante et de la Recherche Medicale (INSERM) 1117408*

  • Use of benzenesulphonyl(thio)ureas for the treatment of dysfunctions of the autonomius nervous system
    Aventis Pharma Deutschland 1117409*

  • Use of bisphosphonic acid derivatives for preparing a medicine for treating lameness
    Ceva Sante Animale 1117410*

  • Process for the preparation of oral pharmaceutical compsns comprising bisphosphonates
    F. Hoffmann-La Roche 1117411*

  • Compsns containing disphosphic acids
    F Hoffmann-La Roche 1117412*

  • Transplantation of neural cells for the treatment of chronic pain or spasticity
    Diacrin 1117413*

  • Reduction of oxidative stress factors
    Probi 1117414*

  • Use of extracts from Aristolochia in the treatment of AIDS
    Proteome Sciences 1117415*

  • Plant extracts for the treatment of increased bone resorption
    Muehlbauer, Roman Conrad 1117416*

  • Pharmaceutically active plant preparation for the treatment of migraine
    Hexal 1117417*

  • Plant extracts forthe treatment of increased bone resorption
    Muehlbauer, Roman Conrad 1117418*

  • Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions
    University of Southern California 1117419*

  • Pharmaceutical compsn based on alpha-cyclodextrin for the oral administration of LH-RH analogues
    Laboratoires Theramex 1117420*

  • Methods for therapeutic vaccination
    M&E Biotech 1117421*

  • Null IGF for the treatment of cancer
    Celtrix Pharmaceuticals 1117427*

  • Methods for the treatment of non-thyroid disorders
    Celtrix Pharamceuticals 1117426*

  • AKT compsns for enhancing survival of cells
    St Elizabeth's Medical Centre 1117426*

  • Use of PEX in the treatment of metabolic bone diseases
    McGill University 1117427*
  • You may also like